Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Aulos Bioscience, Inc.
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
EMD Serono
Fate Therapeutics
Jules Bordet Institute